Please login to the form below

Not currently logged in
Email:
Password:

tiotropium bromide

This page shows the latest tiotropium bromide news and features for those working in and with pharma, biotech and healthcare.

Boehringer starts to feel impact of Spiriva generics

Boehringer starts to feel impact of Spiriva generics

The privately-held German pharma company said this morning that sales of Spiriva (tiotropium bromide) declined 16% to 1.45bn in the first six months of the year thanks to the ... combination therapy Spiolto/Stiolto (tiotropium plus olodaterol).

Latest news

  • Forest Labs launches COPD drug Tudorza in US

    Tudorza (aclidinium bromide) is a long-acting muscarinic antagonist (LAMA) originally developed by Spain's Almirall and is already on the market in Germany, the UK and Denmark, where it is ... It is however likely to see stiff competition from other

  • Breathing easier

    While there are several therapies currently in late-stage clinical trials for COPD — including aclidinium bromide (Eklira, Almirall Prodesfarma/Forest Laboratories), vilanterol/fluticasone furoate (Relovair, GSK), andolast (Rottapharm Madaus) and

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics